Acquisition Responds to Customer Needs in Regenerative Medicine Market

Instron is pleased to announce the acquisition of Tissue Growth Technologies (TGT), a premier supplier of commercial bioreactors to grow and stimulate developing tissues. This alliance offers an instrumentation platform that is uniquely designed to cater to all aspects of tissue engineering, including evaluating cell function, in the emerging regenerative medicine market.


TGT’s modular DynaGen® growth systems have been developed in response to customer demands and provide the capability for repeatable tissue growth. The instrumentation can be configured with samples driven from a controller and computer. This platform sets the standard for mechanically stimulated tissue growth systems.